| Literature DB >> 26729408 |
Xiaoyu Zhang1, Lingling Ding1, Lei Yang1, Wei Qin1, Yue Li1, Shujuan Li1, Wenli Hu1.
Abstract
BACKGROUND: Penumbra has been detected on the edge of white matter hyperintensities (WMH). The aim of our study was to investigate whether cavity formation is different between acute infarcts on the edge of WMH and those away from the edge. MATERIAL/Entities:
Mesh:
Year: 2016 PMID: 26729408 PMCID: PMC4750729 DOI: 10.12659/msm.896324
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1Pixilated method used to measure infarct size. Infarct region was amplified and pixilated (A, B). Pixel value of each pixel on the borderline of a lacunar infarct was obtained (C). We defined the sites with the most changed pixel values as the borderline of lacunar infarction in the direction of largest diameter and measured the infarct size (D).
Figure 2Spatial relationship between acute lacunar infarct and WMH. Grade 0, no contact between acute lacunar infarct and WMH; Grade Ia, contact without overlap between acute lacunar infarct and WMH; Grade Ib, partial overlap between acute lacunar infarct and WMH; and Grade II, acute lacunar infarct appeared complete within a pre-existing white matter hyperintensities (grade II imaging was from a subject without follow-up imaging).
Basic characteristics between subjects with follow-up imagings and without follow-up imagings.
| Subjects with follow-up imagings (n=96) | Subjects without follow-up imagings (n=170) | ||
|---|---|---|---|
| Demographics | |||
| Age, years | 64.81±10.69 | 63.75±10.96 | 0.446 |
| Sex, male | 67 (69.8%) | 123 (72.4%) | 0.657 |
| Vascular risk factors | |||
| Hypertension | 61 (63.5%) | 111 (65.3%) | 0.774 |
| Diabetes | 43 (44.8%) | 61 (35.9%) | 0.153 |
| Hyperlipidemia | 28 (29.2%) | 35 (20.6%) | 0.114 |
| Coronary artery disease | 18 (18.8%) | 19 (11.2%) | 0.086 |
| Stroke or TIA | 29 (30.2%) | 45 (26.5%) | 0.514 |
| Smoking | 56 (58.3%) | 90 (52.9%) | 0.396 |
| Alcohol use | 43 (44.8%) | 61 (35.9%) | 0.153 |
| Laboratory tests | |||
| Hemoglobin, g/L | 138.34±14.84 | 140.24±15.60 | 0.335 |
| Triglyceride, | 1.37 (1.00, 2.18) | 1.31 (0.92, 1.91) | 0.143 |
| Cholesterol, mmol/L | 4.84±1.29 | 4.68±1.01 | 0.256 |
| Low density lipoprotein, mmol/L | 2.73±0.79 | 2.66±0.66 | 0.467 |
| High density lipoprotein, mmol/L | 1.23±0.36 | 1.23±0.33 | 0.966 |
| Hemoglobin A1c, | 6.30 (5.70, 7.90) | 6.10 (5.60, 7.20) | 0.165 |
| Homocysteine, | 16.00 (13.25, 19.75) | 17.00 (14.00, 20.00) | 0.432 |
| Blood urea nitrogen, | 4.30 (3.60, 5.28) | 4.60 (3.90, 5.60) | 0.168 |
| Serum creatinine, | 77.80 (68.25, 93.18) | 80.40 (64.90, 93.10) | 0.925 |
| Uric acid, μmol/L | 293.72±88.86 | 364.20±92.10 | 0.367 |
| NIHSS at admission | 3 (1, 5) | 3 (1, 5) | 0.759 |
| Sites of acute lacunar infarcts | |||
| Subcortical white matter | 45 (46.9%) | 80 (47.1%) | 0.442 |
| Basal ganglia | 11 (11.5%) | 31 (18.2%) | |
| Thalamus | 15 (15.6%) | 24 (14.1%) | |
| Infratentorial region | 25 (26.0%) | 35 (20.6%) | |
| Infarct size at baseline (mm) | |||
| DWI | 12.74±4.46 | 13.11±4.67 | 0.524 |
| T1 | 11.63±4.45 | 11.82±4.47 | 0.737 |
| T2 | 12.55±4.27 | 13.08±4.41 | 0.342 |
| FLAIR | 12.62±3.84 | 13.40±3.98 | 0.123 |
| Total WMH (Fazekas scale) | 3 (2, 4) | 3 (2, 4.25) | 0.786 |
| Mild (0–2) | 41 (42.7%) | 79 (40.6%) | |
| Moderate (3–4) | 32 (33.4%) | 59 (34.8%) | |
| Severe (5–6) | 23 (23.9%) | 42 (24.8%) | |
| Periventricular WMH (Fazekas scale) | 2 (1, 2) | 2 (1, 3) | 0.932 |
| Subcortical WMH (Fazekas scale) | 1 (1, 2) | 1 (1, 2) | 0.756 |
| Edge group | 37 (38.5%) | 56 (33.0%) | 0.358 |
TIA – transient ischemic attack; NIHSS – NIH Stroke Scale; DWI – diffusion-weighted imaging; FLAIR – fluid-attenuated inversion recovery; WMH – white matter hyperintensities.
Continuous variables with non-normal distribution are expressed as median (interquartile range).
Basic characteristics and cavity formation between subjects in edge group and non-edge group.
| Edge group (n=37) | Non-edge group (n=59) | ||
|---|---|---|---|
| Age, years | 64.11±10.89 | 65.25±10.63 | 0.271 |
| Sex, male | 26 (70.3%) | 41 (69.5%) | 0.936 |
| Hypertension | 19 (51.4%) | 42 (71.2%) | 0.049 |
| Diabetes | 15 (40.5%) | 28 (47.5%) | 0.507 |
| Hyperlipidemia | 11 (29.7%) | 17 (28.8%) | 0.923 |
| Coronary artery disease | 4 (10.8%) | 14 (23.7%) | 0.115 |
| Stroke or TIA | 12 (32.4%) | 17 (28.8%) | 0.707 |
| Smoking | 23 (62.2%) | 33 (55.9%) | 0.547 |
| Alcohol use | 13 (35.1%) | 30 (50.8%) | 0.132 |
| Hemoglobin, g/L | 137.95±13.83 | 138.59±15.55 | 0.565 |
| Triglyceride, | 1.46 (0.90, 2.63) | 1.36 (1.05, 2.06) | 0.332 |
| Cholesterol, mmol/L | 4.95±1.43 | 4.77±1.20 | 0.442 |
| Low density lipoprotein, mmol/L | 2.70±0.68 | 2.74±0.85 | 0.893 |
| High density lipoprotein, mmol/L | 1.20±0.36 | 1.25±0.37 | 0.129 |
| Hemoglobin A1c, % | 6.76±1.56 | 7.21±2.04 | 0.632 |
| Homocysteine, | 17.00 (14.00, 18.50) | 16.00 (13.00, 20.00) | 0.782 |
| Blood urea nitrogen, | 4.10 (3.40, 5.75) | 4.50 (4.00, 5.20) | 0.055 |
| Serum creatinine, | 74.80 (68.60, 92.55) | 81.00 (68.00, 94.60) | 0.740 |
| Uric acid, μmol/L | 275.09±90.56 | 305.41±86.50 | 0.417 |
| NIHSS at admission | 3.68±3.17 | 3.17±2.25 | 0.434 |
| Sites of acute lacunar infarcts | |||
| Subcortical white matter | 35 (94.6%) | 10 (16.9%) | |
| Basal ganglia | 0 | 11 (18.6%) | |
| Thalamus | 1 (2.7%) | 14 (23.7%) | |
| Infratentorial region | 1 (2.7%) | 24 (40.7%) | |
| Infarct size at baseline (mm) | |||
| DWI | 13.55±4.49 | 12.23±4.40 | 0.831 |
| T1 | 12.40±4.69 | 11.14±4.26 | 0.896 |
| T2 | 13.47±4.39 | 11.97±4.13 | 0.536 |
| FLAIR | 13.38±3.42 | 12.15±4.04 | 0.205 |
| Total WMH (Fazekas scale) | 4 (2, 5) | 2 (1, 4) | 0.059 |
| Mild (0–2) | 11 (29.7%) | 30 (50.8%) | |
| Moderate (3–4) | 10 (27.0%) | 22 (37.2%) | |
| Severe (5–6) | 16 (43.2%) | 7 (11.9%) | |
| Periventricular WMH (Fazekas scale) | 2 (1, 3) | 2 (1, 2) | 0.046 |
| Subcortical WMH (Fazekas scale) | 2 (1, 2.5) | 1 (1, 2) | 0.163 |
| Cavity formation | 29 (78.4%) | 26 (44.1%) | 0.001 |
TIA – transient ischemic attack; NIHSS – NIH Stroke Scale; DWI – diffusion-weighted imaging; FLAIR – fluid-attenuated inversion recovery; WMH – white matter hyperintensities.
Continuous variables with non-normal distribution are expressed as median (interquartile range);
p<0.05 between subjects in edge group and non-edge group.
Baseline characteristics between subjects with cavity formation and without cavity formation.
| Cavity formation (n=55) | No cavity formation (n=41) | ||
|---|---|---|---|
| Age, years | 64.64±11.38 | 65.05±9.82 | 0.853 |
| Sex, male | 38 (69.1%) | 29 (70.7%) | 0.863 |
| Hypertension | 31 (56.4%) | 30 (73.2%) | 0.091 |
| Diabetes | 22 (40.0%) | 21 (51.2%) | 0.274 |
| Hyperlipidemia | 15 (27.3%) | 13 (31.7%) | 0.636 |
| Coronary artery disease | 12 (21.8%) | 6 (14.6%) | 0.372 |
| Stroke or TIA | 14 (25.5%) | 15 (36.6%) | 0.240 |
| Smoking | 31 (56.4%) | 25 (61.0%) | 0.650 |
| Alcohol use | 22 (40.0%) | 21 (51.2%) | 0.274 |
| Hemoglobin, g/L | 137.44±14.95 | 139.56±14.80 | 0.491 |
| Triglyceride, | 1.36 (0.98, 2.12) | 1.42 (1.06, 2.42) | 0.844 |
| Cholesterol, mmol/L | 4.86±1.41 | 4.81±1.12 | 0.870 |
| Low density lipoprotein, mmol/L | 2.72±0.80 | 2.73±0.78 | 0.928 |
| High density lipoprotein, mmol/L | 1.23±0.37 | 1.24±0.35 | 0.908 |
| Hemoglobin A1c, | 6.10 (5.70, 7.10) | 7.00 (5.70, 8.95) | 0.076 |
| Homocysteine, | 16.00 (13.00, 19.00) | 16.00 (14.00, 23.00) | 0.730 |
| Blood urea nitrogen, mmol/L | 4.68±2.02 | 4.81±1.69 | 0.738 |
| Serum creatinine, μmol/L | 82.02±31.67 | 85.83±23.61 | 0.519 |
| Uric acid, μmol/L | 299.27±99.12 | 286.79±78.62 | 0.482 |
| NIHSS at admission | 3.60±2.51 | 3.05±2.79 | 0.313 |
| Sites of acute lacunar infarcts | |||
| Subcortical white matter | 33 (60.0%) | 12 (29.2%) | 0.006 |
| Basal ganglia | 2 (3.6%) | 9 (22.0%) | |
| Thalamus | 8 (14.5%) | 7 (17.1%) | |
| Infratentorial region | 12 (21.8%) | 13 (31.7%) | |
| Infarct size at baseline (mm) | |||
| DWI | 13.72±4.48 | 11.42±4.13 | 0.012 |
| T1 | 12.52±4.56 | 10.43±4.04 | 0.021 |
| T2 | 13.41±4.35 | 11.39±3.92 | 0.021 |
| FLAIR | 13.37±3.57 | 11.62±4.00 | 0.026 |
| Total WMH (Fazekas scale) | 3 (2, 5) | 2 (1, 4) | 0.082 |
| Mild (0–2) | 20 (36.4%) | 21 (51.2%) | |
| Moderate (3–4) | 18 (32.8%) | 14 (34.2%) | |
| Severe (5–6) | 17 (30.9%) | 6 (14.7%) | |
| Periventricular WMH (Fazekas scale) | 2 (1, 3) | 1 (1, 2) | 0.257 |
| Subcortical WMH (Fazekas scale) | 1 (1, 2) | 1 (1, 2) | 0.050 |
| Edge group | 29 (52.7%) | 8 (19.5%) | 0.001 |
| Time to follow-up (months) | 11.78±7.76 | 14.80±9.01 | 0.077 |
TIA – transient ischemic attack; NIHSS – NIH Stroke Scale; DWI – diffusion-weighted imaging; FLAIR – fluid-attenuated inversion recovery; WMH – white matter hyperintensities.
Continuous variables with non-normal distribution are expressed as median (interquartile range).
p<0.05 between subjects with cavity formation and those without cavity formation.
Baseline predictors for cavity formation.
| Baseline variables | n | Cavity formation | ||
|---|---|---|---|---|
| β | Exp(B) 95% CI | |||
| Infarct size on DWI | 96 | 0.118 | 0.032 | 1.126 (1.010, 1.254) |
| Edge group | 96 | 1.458 | 0.003 | 4.298 (1.651, 11.188) |
DWI – diffusion-weighted imaging. Logistic regression were performed to determine independent predictors for lacune formation after adjustment for age, sex, infarct sites, periventricular WMH and deep WMH in model.